AZ’ experimental asthma drug fails in Phase III
admin 2nd November 2017 Uncategorised 0An experimental therapy being developed by AstraZeneca and its biologics research and development arm MedImmune has failed to hit key targets in two Phase III trials.
More: AZ’ experimental asthma drug fails in Phase III
Source: News